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The measurement of steroid hormone receptors is now a well-recognized common laboratory procedure (McGuire, 1980) . This is due to the fact that breast cancer patients whose tumours contain both oestradiol (RE) and progesterone receptors (RP) are likely to respond in 75% of cases to endocrine treatment (Osborne & McGuire, 1979) whereas this proportion is only 10% for tumours without such receptors (McGuire, 1980) .
The most common measurement technique involving the use of dextran-coated charcoal (DCC) (McGuire, 1977) has certain intrinsic limits: a separate cytosol fraction is required for measurement of each receptor (Allegra et al., 1979) . This necessitates a relatively large quantity of material that can only be obtained from a surgical specimen. This constraint considerably limits the applicability of receptor measurements, especially for the study of tumours in situ, despite the fact that the cellular heterogeneity of breast cancer is well-known (Hawkins et al., 1977) . Although several authors have described the possibility of measuring steroid receptors in needle biopsy samples, it is difficult to evaluate several receptors in a single sample (Poulsen et al., 1979; Delarue et al., 1981) . A recent method has been described for the simultaneous measurement of both RE this method difficult to utilize on a routine basis (Thibodeau et al., 1981) . A combination of the DCC technique and high pressure liquid chromatography (HPLC) has also been reported (Magdalenat, 1979) . We adopted this last technique and attempted to determine its validity by correlation with the routine DCC technique and evaluation of its reproducibility.
Materials and methods

Collection of samples
The present study is based on the analysis of RE and RP measurements obtained by two methods: the method developed by us and the classical DCC method of McGuire et at. (1977) realized for RP by Pichon & Milgrom (1977) and used here on a routine basis. Following histological examination, fragments of the various tumours are divided into two parts; one was used for the simultaneous measurement of RE and RP receptors which provides an immediate result for the clinician; the other (200-500 mg) was rapidly placed in liquid nitrogen for later use in the comparative study.
Samples were selected on the basis of the initial results in order to provide objective coverage of the range of values generally observed. The comparative study thus covered tumours from 26 patients. At the time of assay, tumour fragments were assessed by the two methods: the classical method used previously (in order to avoid a bias in results caused by freezing and thawing) and the micromethod described herein. Preparation of cytosols: (a) For the usual method (cytosol A) the tumour fragment stored in liquid nitrogen was ground and pulverized under liquid nitrogen using a Thermovac pulverizer (Ind Corp., Copiague, New York USA). The fine powder obtained was then placed in 10vol buffer R. This solution was homogenized using a Polytrom PT 10-20 homogenizer (Brinkman Instrument. Inc. Lucerne, Switzerland) at a speed setting of 6 for 3 x 5 sec. intervals, in an ice-bath. The homogenate was then centrifuged for 40 min at 105,000g at 2°C (Kontron Ultracentrifuge Unit, France).
(b) For the microassay (cytosol B), after pulverization with the Thermovac pulverizer (only one pulse), the fine powder (30 mg) was completely recovered with a small spatula (the tip of which has been cooled in liquid nitrogen) and was homogenized in 300pl of buffer R with a glassglass Potter homogenizer in an ice bath. The homogenate was then centrifuged for 40 min at 105,000g. Each test was conduced twice. Incubation lasted 16h at 2°C for RE and 2h at 2°C followed by 2h at 2°C in the presence of 100 M1 of a solution glycerol/Buffer R (60/40, v/v) for RP. Upon completion of incubation, 500 u1 of DCC-A solution prepared 24h earlier were added to each tube. For RE, incubation lasted 30min at 2°C; for RP, 15min at 2°C under vigorous shaking. Tubes were centrifuged for 20min at 2800g at 2°C and 500 1 of supernatant were counted for radioactivity with 4.5ml of Picofluor 30 (Packard). Fifty-pl of cytosol were used to determine protein concentration using the Lowry method.
Methods
Calculation: The specific binding for each hormone was determined by subtracting the nonspecific binding from the total binding. The RE level considered was the mean of the two values of specific binding obtained at the two saturating concentrations (5nM and 10nM). RP level determinations at the two saturating concentrations (12nM and 20nM) were performed in the same way. Micro measurement for RE and RP Principle: The method involves 3 successive steps: (i) incubation of the cytosol B and separation of the free hormones by DCC (ii) precipitation of the proteins and extraction of the hormones bound to the receptors and (iii) separation of the hormones by HPLC and measurement of the radioactivity of the various fractions eluted.
Step I Cytosol incubation was identical to the reference method, except that [3H] oestradiol and [3H] R5020 are co-incubated in the same 100pI aliquot of cytosol. Only one concentration of labelled hormone was utilized, i.e. [3H] oestradiol-7.5 nM (final concentration) and [3H] R5020 15 nM (final concentration). The non-specific tinding was evaluated on another 100 u aliquot by repeating the incubation in the presence of dry extract of unlabelled hormones: 100 times more DES and 200 times more R5020. Incubation was carried out for 16h at 2°C, after which IOOj,l of the DCC-B solution were introduced; following 15 min of incubation at 2°C, centrifugation was conducted for 20min at 2800g, 2°C.
Step 2 To 200pl of supernatant, 200M1 of pure ethanol and 20pl of an aqueous solution of 5% trichloracetic acid were added, the tubes were placed on an agitator for 2h at 2°C, then centrifuged for 20min at 2800g at 2°C; the final supernatant was then available for separation by HPLC.
Step 3 The HPLC system included a 6000 A pump (Waters Assoc., Milford, Ma. USA), a U6K injector (Waters), a Model 440 absorbance detector (Waters) fitted with a 254 nm interferential filter and a Data Module integrator (Waters). Chromatographic separation of the steroids was performed with a radial compression system (RCM 100, Waters), using Rad-Pak cartridges filled with 5pm microparticles of reversed phase C18 (Waters). The elution was performed with a gradient system methanol-water: buffer A, 72% methanol, 28% double-distilled water, v/v; buffer B, 85% methanol, 15% double-distilled water, v/v. Initial conditions 100% A, 0% B; final conditions 0% A, 100% B. Curve N°8: 0-8min, curve No 11: 8-15min (System controller, Waters). The flow rate was 2.5mlmin-1.
Unlabelled aliquots (100p1) of oestradiol (10-4M) R5020 (5 x 10-5M) and dexamethasone (5 x 10-5M) were first injected to identify the respective retention times of these steroids at 254nm. The UV detector and the recorder were then disconnected and 100pl of supernatant from the extraction stage were injected. Fractions (625 p1) were collected at the column outlet (one fraction every 15 sec at a flow rate of 2.5 ml min-1). Picofluor 30 scintillating fluid (4.5 ml) was added, the tubes mixed well and the radioactivity measured on a Packard LS Spectrometer.
Calculation: For every peak corresponding to the retention time of each steroid, the specific binding was calculated by subtracting the peak related to incubation in the presence of labelled hormone and an excess of unlabelled hormone (non-specific binding) from the peak for incubation in the presence of labelled hormone only (total binding).
The results are expressed in fmol mg-' protein.
Results
Figure 1 corresponds to the chromatogram obtained after injection of a mixture of unlabelled (la) and labelled (lb) oestradiol, R5020 and dexamethasone. The chromatographic separation allows the identification of all 3 steroids. Figure 2 represents an HPLC profile allowing the quantification of RE and RP following incubation of a cytosol from a tumour specimen.
Comparison of the results obtained using the reference method and our microassay is provided in Figure 3 48 39 CV = 11.9% CV = 9.5% 2 x 5 aliquots from one cytosol were used for the determination of the total and the non-specific binding as described in Materials and methods. ND = not determined.
CV =coefficient of variation.
extraction of the steroids bound to the receptors, their separation by HPLC and their collection and quantification. This work represents a novel application of HPLC which appears at present to be one of the most valuable techniques in clinical biochemistry (Elin, 1980) . Connection of a continuous flux radioactivity detector at the outlet of the chromatograph may be used in order to allow automatic analysis. This study was centred on the two main receptors-RE and RP-since their evaluation has proved useful in the clinical management of breast cancer (Saez, 1981) . However, the chromatographic conditions we have established also permit separation of dexamethasone from the two other hormones, thereby increasing the method's potential range of application. There is an inherent problem in the inclusion of androgen receptor measurements in this system because of the nearly identical affinity of metribolone (R1881) for androgen and progesterone receptors (Ojasoo & Raynaud, 1978) .
The highly satisfactory correlation observed between the microassay and the DCC reference method implies that the thresholds of positivity established on the basis of the DCC method are not changed by the microassay, and thus should not alter the criteria used by clinicians in decisionmaking. Reproducibility tests revealed coefficients of variation close to 10%, indicating that the microassay is reliable, and obviating replicate measurements. Thus, with as little as 300 pI of cytosol, the protein concentration (50 ul) and the concentration of steroid receptors (2 x 100 M1) could be determined simultaneously. It is generally admitted that the lower limit for the protein concentration in cytosol is 1 mg ml-1 if the DCC technique is to be successful (Poulsen et al., 1979; Leclercq et al., 1973) . On this basis, samples of 20-30mg can be analyzed by the microassay described here. This weight corresponds to the quantity of tissue obtained by a needle biopsy (Delarue et al., 1981) . This method is now used for the simultaneous measurement of RE and RP on biopsy specimens for in situ tumours in breast cancer patients (unpublished data).
The heterogeneity of steroid receptors within a mammary tumour is well established (Hawkins et al., 1977; Poulsen, 1981) . This variability can probably be explained by the histological disparity of mammary tumours (Gairard et al., 1981) , which means that it is advisable to couple each steroid receptor measurement on a biopsy specimen with microanatomical examination of a biopsy sample of a nearby site. For advanced breast cancer there are clinical indications preceding surgical intervention by combined radiotherapy and chemotherapy (Bruckmann et al., 1979 (McGuire, 1980) . To resolve this discrepancy, it would be interesting to conduct a sequential study based on
